An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized TrialMasahiro Natsuaki, Takeshi Kimura, Ryusuke Nishikawa et al.|Circulation|2023Cited by 145
Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent ThrombosisShoichi Kuramitsu, Masanobu Ohya, Tomohiro Shinozaki et al.|Circulation Cardiovascular Interventions|2019Cited by 56
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trialHirotoshi Watanabe, Takeshi Kimura, Masahiro Natsuaki et al.|European Heart Journal|2024Cited by 37